Spectral Competitors
| MDAI Stock | 1.42 0.04 2.90% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Spectral competition on your existing holdings.
As of now, Spectral's Return On Capital Employed is increasing as compared to previous years. The Spectral's current Return On Equity is estimated to increase to 2.76, while Return On Tangible Assets are projected to decrease to (1.33). As of now, Spectral's Total Current Assets are increasing as compared to previous years. The Spectral's current Debt To Assets is estimated to increase to 0.41, while Net Tangible Assets are projected to decrease to under 9.9 M. Spectral Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Spectral and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Spectral and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Spectral AI does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Spectral Stock performing well and Spectral Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Spectral's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ICCM | 2.40 | (0.80) | 0.00 | (0.68) | 0.00 | 4.35 | 13.54 | |||
| TELA | 2.70 | (0.33) | 0.00 | (4.36) | 0.00 | 4.42 | 22.47 | |||
| CTSO | 3.57 | (0.50) | 0.00 | (0.45) | 0.00 | 7.58 | 29.40 | |||
| SRTS | 2.84 | 0.25 | 0.10 | 0.22 | 2.47 | 7.14 | 26.96 | |||
| EQ | 5.84 | 0.23 | 0.05 | 0.16 | 5.46 | 19.26 | 35.57 | |||
| COEP | 2.89 | (0.25) | 0.00 | (0.25) | 0.00 | 5.91 | 22.14 | |||
| IPSC | 3.85 | 1.06 | 0.19 | 0.69 | 4.33 | 9.80 | 27.66 | |||
| TELO | 3.85 | (0.01) | 0.01 | 0.05 | 4.99 | 5.73 | 41.27 | |||
| ECOR | 2.79 | (0.11) | 0.00 | (0.01) | 0.00 | 5.26 | 30.74 | |||
| KPTI | 3.30 | 0.15 | 0.05 | 0.15 | 3.77 | 8.24 | 16.03 |
Cross Equities Net Income Analysis
Compare Spectral AI and related stocks such as Icecure Medical, Tela Bio, and Cytosorbents Crp Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICCM | (4.6 M) | (4.6 M) | (4.6 M) | (4.6 M) | (4.7 M) | (3.8 M) | (3.3 M) | (2.9 M) | (3.5 M) | (4.8 M) | (4.8 M) | (10.1 M) | (17.2 M) | (14.7 M) | (15.3 M) | (14.6 M) |
| TELA | (21.3 M) | (21.3 M) | (21.3 M) | (21.3 M) | (21.3 M) | (21.3 M) | (21.3 M) | (21.3 M) | (21.1 M) | (22.4 M) | (28.8 M) | (33.3 M) | (44.3 M) | (46.7 M) | (37.8 M) | (39.7 M) |
| CTSO | (80 K) | (5.5 M) | (3.7 M) | (4.7 M) | (9.3 M) | (8.1 M) | (11.9 M) | (8.5 M) | (17.2 M) | (19.3 M) | (7.8 M) | (24.6 M) | (32.8 M) | (29.2 M) | (20.7 M) | (19.7 M) |
| SRTS | 107.6 K | 107.6 K | 107.6 K | 107.6 K | (3.7 M) | (237.3 K) | (346.4 K) | (3.7 M) | (2 M) | (1.7 M) | (6.8 M) | 4.1 M | 24.2 M | 485 K | 6.6 M | 7 M |
| EQ | (2.3 M) | (2.3 M) | (2.3 M) | (2.3 M) | (2.3 M) | (2.3 M) | (2.3 M) | (2.3 M) | (13.2 M) | (25.6 M) | (29.8 M) | (39 M) | (62.4 M) | (13.3 M) | (8.1 M) | (8.5 M) |
| COEP | 2.6 M | (7.1 K) | (7.1 K) | (7.1 K) | (7.1 K) | (7.1 K) | (7.1 K) | (7.1 K) | (7.1 K) | (2.2 K) | (9.2 M) | (13.4 M) | (37.6 M) | (21.3 M) | (10.9 M) | (11.4 M) |
| IPSC | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (53.6 M) | (95.8 M) | (130.9 M) | (136.7 M) | (126.6 M) | (132.9 M) |
| TELO | (138.1 K) | (138.1 K) | (138.1 K) | (138.1 K) | (138.1 K) | (138.1 K) | (138.1 K) | (138.1 K) | (138.1 K) | (138.1 K) | (138.1 K) | (854.1 K) | (13.1 M) | (16.5 M) | (14.9 M) | (14.1 M) |
| ECOR | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (35.8 M) | (55.8 M) | (45.1 M) | (23.5 M) | (17.2 M) | (22.2 M) | (18.8 M) | (11.9 M) | (12.5 M) |
| KPTI | (10.3 M) | (10.3 M) | (15.9 M) | (33.9 M) | (75.8 M) | (118.2 M) | (109.6 M) | (129 M) | (178.4 M) | (199.6 M) | (196.3 M) | (124.1 M) | (165.3 M) | (143.1 M) | (76.4 M) | (80.2 M) |
Spectral AI and related stocks such as Icecure Medical, Tela Bio, and Cytosorbents Crp Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Spectral AI financial statement analysis. It represents the amount of money remaining after all of Spectral AI operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Spectral Competitive Analysis
The better you understand Spectral competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Spectral's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Spectral's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Spectral Competition Performance Charts
Five steps to successful analysis of Spectral Competition
Spectral's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Spectral AI in relation to its competition. Spectral's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Spectral in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Spectral's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Spectral AI, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Spectral position
In addition to having Spectral in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Munis Funds Thematic Idea Now
Munis Funds
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Spectral Correlation with its peers. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spectral. If investors know Spectral will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spectral listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.75) | Revenue Per Share | Quarterly Revenue Growth (0.54) | Return On Assets | Return On Equity |
The market value of Spectral AI is measured differently than its book value, which is the value of Spectral that is recorded on the company's balance sheet. Investors also form their own opinion of Spectral's value that differs from its market value or its book value, called intrinsic value, which is Spectral's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spectral's market value can be influenced by many factors that don't directly affect Spectral's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spectral's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spectral is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spectral's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.